JP2022548698A5 - - Google Patents

Info

Publication number
JP2022548698A5
JP2022548698A5 JP2022517391A JP2022517391A JP2022548698A5 JP 2022548698 A5 JP2022548698 A5 JP 2022548698A5 JP 2022517391 A JP2022517391 A JP 2022517391A JP 2022517391 A JP2022517391 A JP 2022517391A JP 2022548698 A5 JP2022548698 A5 JP 2022548698A5
Authority
JP
Japan
Prior art keywords
polymer
group
integer
pharmaceutical composition
polymer according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022517391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548698A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051499 external-priority patent/WO2021055752A1/en
Publication of JP2022548698A publication Critical patent/JP2022548698A/ja
Publication of JP2022548698A5 publication Critical patent/JP2022548698A5/ja
Priority to JP2024202452A priority Critical patent/JP2025019142A/ja
Withdrawn legal-status Critical Current

Links

JP2022517391A 2019-09-20 2020-09-18 ベンゾオキサボロールポリマーおよび使用方法 Withdrawn JP2022548698A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024202452A JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962903332P 2019-09-20 2019-09-20
US62/903,332 2019-09-20
PCT/US2020/051499 WO2021055752A1 (en) 2019-09-20 2020-09-18 Benzoxaborole polymers and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024202452A Division JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Publications (2)

Publication Number Publication Date
JP2022548698A JP2022548698A (ja) 2022-11-21
JP2022548698A5 true JP2022548698A5 (https=) 2023-09-28

Family

ID=74884685

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517391A Withdrawn JP2022548698A (ja) 2019-09-20 2020-09-18 ベンゾオキサボロールポリマーおよび使用方法
JP2024202452A Pending JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024202452A Pending JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Country Status (4)

Country Link
US (1) US20220396651A1 (https=)
EP (1) EP4041740A4 (https=)
JP (2) JP2022548698A (https=)
WO (1) WO2021055752A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022003384A (es) 2019-09-20 2022-06-27 Glyscend Inc Polimeros que contienen acido fenil boronico sustituido y metodos de uso.
AR134545A1 (es) * 2023-12-04 2026-01-28 Aviko Radiopharmaceuticals Llc Compuestos de arilo bicíclico fusionado para terapia de captura de neutrones en boro
TW202541817A (zh) * 2023-12-28 2025-11-01 美商艾維克放射性藥物股份有限公司 用於硼中子捕獲療法之稠合雙環芳基化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3413898B2 (ja) * 1993-09-14 2003-06-09 満 明石 高分子化合物およびその製造方法
AU2003291567A1 (en) * 2002-11-19 2004-06-15 Genzyme Corporation Polymeric boronic acid derivatives as lipase inhibitors
EP2226075A1 (en) * 2007-11-22 2010-09-08 The University of Tokyo Material for preventing tissue adhesion and material for preventing joint contracture
EP3331499A4 (en) * 2015-08-06 2019-04-10 The Johns Hopkins University COMPOSITION AND METHOD FOR THE TREATMENT OF METABOLISM DISEASES
WO2017061435A1 (ja) * 2015-10-06 2017-04-13 国立研究開発法人物質・材料研究機構 ビニルアルコール樹脂機能化方法並びにビニルアルコール樹脂機能化剤
JP6630761B2 (ja) * 2018-03-06 2020-01-15 株式会社竹村製作所 樹脂管用継手
CN108478779B (zh) * 2018-04-12 2021-06-04 南京邮电大学 一种肿瘤靶向纳米药物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2022548698A5 (https=)
ES3031577T3 (en) Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof
US11939361B2 (en) Compositions of peptide inhibitors of Interleukin-23 receptor
JP6581625B2 (ja) 代謝障害を治療するための組成物および方法
CN110051638B (zh) 包含双胍的延迟释放组合物
US20200171179A1 (en) High molecular weight zwitterion-containing polymers
TWI834838B (zh) 化合物之調配物及其用途
US20180117168A1 (en) Cyclodextrin-based polymers for therapeutic delivery
AU2018255933A1 (en) Sustained release delivery systems comprising traceless linkers
JP2022548699A5 (https=)
JP6704900B2 (ja) ポリオキサゾリン抗体薬物複合体
JP2013520561A5 (https=)
CA3216091A1 (en) Oral delivery of oligonucleotides
JP2019514908A5 (https=)
JP2023145581A (ja) インターロイキン－２３受容体のペプチド阻害剤の組成物
US20230028715A1 (en) Il-31 modulators for treating fxr-induced pruritis
JP2008120708A (ja) フロリジン誘導体ならびにその製造方法
Gelb Safer Polymer Formulations for Stabilizing Protein Therapeutics
WO2025099561A1 (en) Oral controlled-release matrix formulations of 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof
HK40012109B (zh) 包含双胍的延迟释放组合物
HK40012109A (en) Delayed-release composition comprising biguanide
Griener Impact of the nature and size of the polymeric backbone on the ability of heterobifunctional ligands to mediate shiga toxin and serum amyloid p component ternary complex formation